Exagen Statistics
Total Valuation
Exagen has a market cap or net worth of $44.68 million. The enterprise value is $44.30 million.
Important Dates
The next confirmed earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Exagen has 17.39 million shares outstanding. The number of shares has increased by 3.16% in one year.
Shares Outstanding | 17.39M |
Shares Change (YoY) | +3.16% |
Shares Change (QoQ) | +1.30% |
Owned by Insiders (%) | 13.10% |
Owned by Institutions (%) | 27.50% |
Float | 6.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.81 |
Forward PS | 0.77 |
PB Ratio | 2.54 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.32, with a Debt / Equity ratio of 1.37.
Current Ratio | 4.32 |
Quick Ratio | 3.83 |
Debt / Equity | 1.37 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.08 |
Financial Efficiency
Return on equity (ROE) is -69.97% and return on invested capital (ROIC) is -19.91%.
Return on Equity (ROE) | -69.97% |
Return on Assets (ROA) | -17.41% |
Return on Capital (ROIC) | -19.91% |
Revenue Per Employee | $316,536 |
Profits Per Employee | -$96,726 |
Employee Count | 179 |
Asset Turnover | 1.00 |
Inventory Turnover | 10.23 |
Taxes
In the past 12 months, Exagen has paid $33,000 in taxes.
Income Tax | 33,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.29% in the last 52 weeks. The beta is 1.32, so Exagen's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | +50.29% |
50-Day Moving Average | 2.88 |
200-Day Moving Average | 2.16 |
Relative Strength Index (RSI) | 42.53 |
Average Volume (20 Days) | 16,674 |
Short Selling Information
The latest short interest is 23,450, so 0.13% of the outstanding shares have been sold short.
Short Interest | 23,450 |
Short Previous Month | 15,746 |
Short % of Shares Out | 0.13% |
Short % of Float | 0.35% |
Short Ratio (days to cover) | 0.98 |
Income Statement
In the last 12 months, Exagen had revenue of $56.66 million and -$17.31 million in losses. Loss per share was -$0.97.
Revenue | 56.66M |
Gross Profit | 33.51M |
Operating Income | -15.81M |
Pretax Income | -17.28M |
Net Income | -17.31M |
EBITDA | -13.81M |
EBIT | -15.81M |
Loss Per Share | -$0.97 |
Full Income Statement Balance Sheet
The company has $24.48 million in cash and $24.10 million in debt, giving a net cash position of $383,000 or $0.02 per share.
Cash & Cash Equivalents | 24.48M |
Total Debt | 24.10M |
Net Cash | 383,000 |
Net Cash Per Share | $0.02 |
Equity (Book Value) | 17.59M |
Book Value Per Share | 1.01 |
Working Capital | 31.35M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$6.03 million and capital expenditures -$330,000, giving a free cash flow of -$6.36 million.
Operating Cash Flow | -6.03M |
Capital Expenditures | -330,000 |
Free Cash Flow | -6.36M |
FCF Per Share | -$0.37 |
Full Cash Flow Statement Margins
Gross margin is 59.13%, with operating and profit margins of -27.90% and -30.56%.
Gross Margin | 59.13% |
Operating Margin | -27.90% |
Pretax Margin | -30.50% |
Profit Margin | -30.56% |
EBITDA Margin | -24.37% |
EBIT Margin | -27.90% |
FCF Margin | -11.18% |
Dividends & Yields
Exagen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.16% |
Shareholder Yield | -3.16% |
Earnings Yield | -38.75% |
FCF Yield | -14.22% |
Analyst Forecast
The average price target for Exagen is $7.00, which is 172.37% higher than the current price. The consensus rating is "Buy".
Price Target | $7.00 |
Price Target Difference | 172.37% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 14.15% |
EPS Growth Forecast (5Y) | -13.30% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Exagen has an Altman Z-Score of -6.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -6.62 |
Piotroski F-Score | 3 |